Human medicines European public assessment report (EPAR): Alecensa, alectinib, Carcinoma, Non-Small-Cell Lung, Date o...

Human medicines European public assessment report (EPAR): Alecensa, alectinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 16/02/2017, Revision: 14, Status: Authorised Human medicines European public assessment report (EPAR): Alecensa, alectinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 16/02/2017, Revision: 14, Status: Authorised

Wil je het laatste nieuws in jouw mailbox ontvangen?
Meld je dan aan voor de nieuwsbrief.